Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophageal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01249352
What this trial is testing

Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal CancerAdenocarcinoma
Eurofarma Laboratorios S.A. 104
Not applicableUnknownNCT05053295
What this trial is testing

Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer

Who this might be right for
Relapsed or Advanced Gastric AdenocarcinomaGastro-esophageal Junction Cancer
Gangnam Severance Hospital 20
Testing effectiveness (Phase 2)UnknownNCT00057395
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Who this might be right for
Esophageal NeoplasmsHepatocellular CarcinomaColorectal Neoplasms+3 more
Aronex Pharmaceuticals 40
Not applicableAvailableNCT04566393
What this trial is testing

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Who this might be right for
Pancreatic CancerSmall Bowel CancerColorectal Cancer+18 more
xCures
Not applicableUnknownNCT03908671
What this trial is testing

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer

Who this might be right for
Esophageal CancerNon Small Cell Lung Cancer
Stemirna Therapeutics 24
Not applicableStudy completedNCT03434834
What this trial is testing

OCT Pilot in Esophagus

Who this might be right for
Barrett Esophagus
Duke University 53
Testing effectiveness (Phase 2)Study completedNCT00730353
What this trial is testing

Sutent + Taxol for Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Hoosier Cancer Research Network 28
Testing effectiveness (Phase 2)Looking for participantsNCT06675201
What this trial is testing

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)
Sichuan University 165
Not applicableUnknownNCT05028231
What this trial is testing

Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapies
Tongji Hospital 46
Testing effectiveness (Phase 2)UnknownNCT05990231
What this trial is testing

Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 35
Testing effectiveness (Phase 2)Looking for participantsNCT03736863
What this trial is testing

A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University 147
Testing effectiveness (Phase 2)Looking for participantsNCT04656041
What this trial is testing

Folfox+Irinotecan+Chemort In Esophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaEsophagogastric Cancer
Massachusetts General Hospital 40
Early research (Phase 1)Active Not RecruitingNCT05539430
What this trial is testing

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal-junction CancerEsophageal Cancer+1 more
Legend Biotech USA Inc 56
Testing effectiveness (Phase 2)UnknownNCT03995017
What this trial is testing

Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma

Who this might be right for
Esophagus Cancer, AdenocarcinomaStomach Cancer, Adenocarcinoma
University of Kansas Medical Center 34
Testing effectiveness (Phase 2)Ended earlyNCT00093652
What this trial is testing

Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT01795976
What this trial is testing

NY-ESO-1 T Cells in OG Cancer

Who this might be right for
Oesophageal Cancer
Fiona Thistlethwaite 2
Testing effectiveness (Phase 2)Looking for participantsNCT02297217
What this trial is testing

Chemoradiotherapy for Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
AHS Cancer Control Alberta 50
Not applicableUnknownNCT05760391
What this trial is testing

IO Plus Radiotherapy in Patients With Advanced ESCC.

Who this might be right for
Metastatic Esophageal Squamous Cell Carcinoma
Fudan University 100
Testing effectiveness (Phase 2)Ended earlyNCT01457846
What this trial is testing

Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer

Who this might be right for
Gastro-oesophageal Junction CancerGastric Cancer
AstraZeneca 960
Testing effectiveness (Phase 2)UnknownNCT05425472
What this trial is testing

A Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer

Who this might be right for
Advanced Esophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 30
Next Page